Mechanistically, RIP1 also plays a role in the initiation of the NF-κB signaling pathway; moreover, accumulating studies have indicated that cytokine release and inflammation trigger the proliferation, survival and metastasis of cancer cells. Here, RIPK1 is linked to cancer.